Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
JoLynn Procter
Observed names:
J. L. Procter,
J. Procter,
J.L. Procter,
Jolynn Procter,
Procter, Jolynn
Observed institutions:
University of Southern California,
National Institutes of Health,
Pennsylvania State University,
Michael Reese Research and Education Foundation,
National Institute of Allergy and Infectious Diseases,
National Institutes of Health Clinical Center
show all 6
ORCID:
0000-0002-4171-9682
Observed ORCID:
0000-0002-4171-9682
OpenAlex ID:
A5073735582
Variations in the expression of granulocyte antigen NB1
2000
·
K. Matsuo
, A. Lin
, et al.
·
Transfusion
·
72
Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome
2003
·
S.‐W. Kwon
, J. Procter
, et al.
·
Vox Sanguinis
·
45
Variations in genes encoding neutrophil antigens NA1 and NA2
2000
·
K. Matsuo
, J. Procter
, et al.
·
Transfusion
·
33
The dantu erythrocyte phenotype of the NE variety
1987
·
P. Unger
, J. L. Procter
, et al.
·
Annals of Hematology
·
31
A preliminary comparison of flow cytometry and tube agglutination assays in detecting red blood cell‐associated C3d
2003
·
D. F. Stroncek
, J. M. Njoroge
, et al.
·
Transfusion Medicine
·
29
Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
2022
·
Daniel S. Green
, Franklin Ning
, et al.
·
Clinical Cancer Research
·
23
PDF
Prospective Evaluation of a Practical Guideline for Managing Positive Sterility Test Results in Cell Therapy Products
2018
·
Sandhya R. Panch
, Thejaswi Bikkani
, et al.
·
Transplantation and Cellular Therapy
·
22
PDF
Description of serologic features in autoimmune lymphoproliferative syndrome
2000
·
L.B. Carter
, J.L. Procter
, et al.
·
Transfusion
·
15
Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use
2019
·
Daniel S. Green
, Ana T. Nunes
, et al.
·
Journal of Translational Medicine
·
12
PDF
Intravenous Rh immune globulin prevents alloimmunization in D– granulocyte recipients but obscures the detection of an alloanti-K
2001
·
D.F. Stroncek
, J. L. Procter
, et al.
·
Immunohematology
·
11
Granulocyte storage and antigen stability
1999
·
H. Chun
, K. Cipolone
, et al.
·
Transfusion
·
11
PDF
A novel method using formamide for the elution of antibodies from erythrocytes
2002
·
L. Caruccio
, K. Byrne
, et al.
·
Vox Sanguinis
·
10
Comparison of tube and gel red blood cell agglutination techniques in detecting chimeras after major ABO-mismatched allogeneic hematopoietic stem cell transplantation
1998
·
M.J. Kupferman
, K.M. Cipolone
, et al.
·
Immunohematology
·
6
In vitro RBC exposure to Plasmodium falciparum has no effect on RBC antigen expression
2002
·
D. R. Chambers
, J. Procter
, et al.
·
Transfusion Medicine
·
4
Detection of granulocyte antibodies by flow cytometry without the use of pure granulocyte isolates
2001
·
K. M. Kiekhaefer
, K. M. Cipolone
, et al.
·
Immunohematology
·
4
Rapid screening of platelet donors for Pl A1 (HPA-1a) alloantigen using a solid-phase microplate immunoassay
1998
·
J.L. Procter
, F. Vigue
, et al.
·
Immunohematology
·
4
Comparison of human platelet antigen (HPA)-1a typing by solid phase red cell adherence to HPA-1 allotypes determined by allelespecific restriction enzyme analysis
2000
·
M.J. Mcgann
, J.L. Procter
, et al.
·
Immunohematology
·
2
Elimination of a requirement for Vel-negative red blood cells and successful transfusion following chromium-51 survival study
1995
·
R.J. Davey
, J.L. Procter
·
Immunohematology
·
2
Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
2023
·
Daniel S. Green
, Franklin Ning
, et al.
·
Clinical Cancer Research
·
1
PDF
Supplementary figures and tables FTS1 from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
2025
·
Daniel S. Green
, Franklin Ning
, et al.
Supplementary Data DS1 from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
2025
·
Daniel S. Green
, Franklin Ning
, et al.
Data from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
2023
·
Daniel S. Green
, Franklin Ning
, et al.
Supplementary Data DS1 from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
2023
·
Daniel S. Green
, Franklin Ning
, et al.
Supplementary figures and tables FTS1 from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
2023
·
Daniel S. Green
, Franklin Ning
, et al.
Supplementary Data DS1 from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
2023
·
Daniel S. Green
, Franklin Ning
, et al.
Show more works
View as search
Works count:
36
Citation count:
337
H-index:
11
I10-index:
12
Year
Topic
Type
